Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

Transplant Proc. 2003 Sep;35(6):2104-5. doi: 10.1016/s0041-1345(03)00680-8.
No abstract available

MeSH terms

  • Acute Disease
  • Adrenal Cortex Hormones / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers
  • Antibody Formation
  • Biopsy
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Graft Rejection / immunology*
  • Graft Rejection / pathology
  • Humans
  • Imidazoles / therapeutic use
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / pathology
  • Losartan / therapeutic use
  • Major Histocompatibility Complex
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Pyridines / therapeutic use
  • Receptor, Angiotensin, Type 1 / immunology*

Substances

  • Adrenal Cortex Hormones
  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • PD 123319
  • Cyclosporine
  • Mycophenolic Acid
  • Losartan